Skip to main content
GWGovwatch
CongressBillsCommitteesPresidentMoneyPulseMisconductElectionsMap
Donate

Weekly accountability digest

One email a week with new votes, moving bills, and misconduct updates. No spam.

GW

Govwatch. Public data about Congress, in one place, in plain English.

Built with public data. Not affiliated with the U.S. government.

Explore

  • Officials
  • Legislation
  • Committees
  • Congress Pulse
  • Trending Topics
  • Bipartisan Leaderboard
  • Weekly Digest
  • Misconduct
  • Predictions

Learn

  • How Congress Works
  • How a Bill Becomes Law
  • Campaign Finance 101
  • Glossary

Tools

  • My Representatives
  • Compare Members
  • Bill Watchlist
  • Search
  • District Map
  • Follow the Money
  • Watch Live

Site

  • About
  • Contact
  • Corrections
  • Privacy Policy
  • Terms of Service

Data Sources

Congress.gov API v3
Bills, members, votes
GovInfo API
Floor speeches, reports, bill text
Federal Election Commission (FEC)
Campaign finance
VoteView (UCLA)
Ideology scores (DW-NOMINATE)
GovTrack.us
Misconduct data (CC0)
U.S. Census Bureau
District demographics
Support This Project

This site is free. Donations help cover hosting, API fees, and keeping the data fresh.

All data is sourced from official government APIs and public records. This site is for informational purposes only.

© 2026 Govwatch

Press ReleaseNeutral2026-03-20

Reps. Dunn and Soto Introduce Bill to Expand Access to Effective Cancer Treatments

Neal P. Dunn
Neal P. Dunn
RFL-2 · Representative
Share:
HealthcareTaxesEnvironmentTrade

Context

This press release from Representative Neal P. Dunn (R-FL) was published on 2026-03-20 and titled "Reps. Dunn and Soto Introduce Bill to Expand Access to Effective Cancer Treatments". It focuses on healthcare and touches on taxes, the environment.

Full Text

Reps. Dunn and Soto Introduce Bill to Expand Access to Effective Cancer Treatments

WASHINGTON, DC– Congressman Neal Dunn, M.D. (FL-02) and Congressman Darren Soto (FL-09) have introduced the Facilitating Access to Innovation in Cancer Care Act (FAIC Act) to ensure cancer patients on Medicare can access the most effective treatments available. Recent breakthroughs in cancer care have produced innovative therapies that improve patient outcomes while reducing long-term healthcare costs. However, flaws in Medicare’s current payment structure have prevented many of these treatments from reaching patients, instead favoring older, less effective options. The FAIC Act addresses this issue by requiring Medicare to reimburse certain cancer drugs separately, rather than bundling them into procedure payments that discourage their use. CMS has acknowledged for years that bundled payment policies can restrict access to necessary treatments. While the agency took steps in 2025 to reverse this policy for certain diagnostic drugs, it has not extended the fix to cancer therapies. The FAIC Act would correct this gap by ensuring these medications are reimbursed appropriately under Medicare Part B. Importantly, the legislation is budget-neutral under Medicare’s outpatient payment system. “As a physician, I have seen firsthand the impact that innovation can have on patient outcomes,” said Congressman Dunn. “This bill ensures Medicare keeps pace with innovation so patients can receive the most effective care. By addressing this issue, we can improve outcomes, reduce recurrence, and ultimately lower costs for patients and taxpayers alike.” “I am honored to work with Dr. Dunn on this effort to ensure Medicare beneficiaries have access to cancer treatments and diagnostics,” said Rep. Soto. “ Cancer patients are a uniquely vulnerable population, and equitable access to treatments regardless of insurance coverage is critical to ensuring their cancer does not spread or return." ###
View original source →